Controlled Endoscopy Study of a Novel Protected Formulation of Oral Alendronate.
The FDA approved alendronate in September 1995.
It is not known if FOSAMAX passes into your milk and may harm your baby. In addition, FOSAMAX 5 mg day reduced the rate of bone loss at the forearm by approximately half relative to placebo.
FOSAMAX is contraindicated in patients with the following conditions. Re-treatment may also be considered in those who failed to normalize their serum alkaline phosphatase. Giant cell arteritis, inflammation of blood vessel walls, affects 10 -15 of polymyalgia rheumatica patients.
What else should I know about alendronate Fosamax. Patients in the study had either a BMD T-score less than or equal to -2 at the femoral neck and less than or equal to -1 at the lumbar spine, or a BMD T-score less than or equal to -2 at the lumbar spine and less than or equal to -1 at the femoral neck, or a baseline osteoporotic fracture and a BMD T-score less than or equal to -1 at the femoral neck.
These data indicate that the rate of bone turnover reached a new steadystate, despite the progressive increase in the total amount of alendronate deposited within bone.
Ask your doctor before use if you are taking the following medications:
The risk of agranulocytosis increased with age and was higher among women.
Avoid administration with grapefruit juice to avoid potential increases in drug serum concentrations.
Protracted parturition due to maternal hypocalcemia occurred in rats at doses as low as one tenth the clinical dose when rats were treated from before mating through gestation. In June 1996, repeated endoscopy showed a normal esophagus and superficial gastritis. Alendronate works by preventing bone breakdown and increasing the thickness of bone.
Joo Park, Jon Clouse, Deborah Shatin, Andy Stergachis. No other interactions with medicinal products of clinical significance are anticipated.